GlassScriptPhysician profile
Everett J Bonner
NPI 1417033739
$620.20
in general payments reported to CMS, 2019-2025
12 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $67.94 · 2021: $80.90 · 2022: $60.66 · 2024: $194 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $150.17 | 2024 | |
| Medtronic, INC. | $80.90 | 2021 | |
| Baxter Healthcare | $76.70 | 2025 | |
| Myriad Genetic Laboratories, INC. | $67.94 | 2020 | |
| Next Science LLC | $60.66 | 2022 | |
| W. L. Gore & Associates, INC. | $41.90 | 2025 | Gore Synecor Biomaterial |
| Tactile Systems Technology INC | $36.55 | 2025 | Flexitouch Plus, Nimbl |
| Heron Therapeutics, INC. | $24.39 | 2025 | Zynrelef |
| Recordati_rare_diseases_inc. | $23.28 | 2024 | Sylvant |
| Hologic Sales and Service, LLC | $21.02 | 2024 | Biozorb |
| Array Biopharma INC | $20.29 | 2025 | Lorbrena, Braftovi, Mektovi |
| Pacira Pharmaceuticals Incorporated | $16.40 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Everett Bonner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.